E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)
From The Evidence Based Rheumatology Podcast by Michael Putman
March 5, 2026 · 14 min · Episode 133
About this episode
This episode discusses a head to head study comparing romosozumab and teriparatide for managing osteoporosis.
Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if - like me - you're still trying to figure out how the heck to manage osteoporosis. Paper: https://pubmed.ncbi.nlm.nih.gov/28755782/
People in this episode
Host: Michael Putman
Topics covered
- osteoporosis
- romosozumab
- teriparatide
- head to head study
- management
- healthcare
Keywords
- osteoporosis
- romosozumab
- teriparatide
- head to head study
- management
- health
- fitness
- medicine
Mentioned in this episode
Books & works: Romosozumab vs teriparatide for osteoproosis, https://pubmed.ncbi.nlm.nih.gov/28755782/
More episodes of The Evidence Based Rheumatology Podcast
- E135: IL17 and a GLP1? · April 30, 2026 · 11 min
- E134: Brepocitinib in Dermatomyositis (VALOR) · April 17, 2026 · 15 min
- E133: Obinutuzumab for SLE (ALLEGORY) · March 19, 2026 · 15 min
- E131: A Sham-Controlled Sham of a Trial: RESET-RA · January 21, 2026 · 15 min
- E130: Telitacicept for SLE · December 22, 2025 · 13 min
- E129: Long Term Routine Laboratory Monitoring in RA · December 4, 2025 · 15 min
Explore listener stats, chart rankings, contacts and more on the The Evidence Based Rheumatology Podcast podcast page.